This session will focus on aspects of endocrine disruption testing that are new or have not received much attention. Developments in in vitro assays for thyroid testing and non-mammalian testing will be highlighted and examined. Use of mode of action studies will illustrate how to determine relevance to human health.
Mira Wenker, PhD
Section Head, Drug Metabolism and Pharmacokinetics
Dan Pickford, PhD
Principal Technical Expert, Environmental Safety, Syngenta
Pramila Singh, PhD
Scientific Director and Senior Director of Toxicology